首页 > 最新文献
paperpass

The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections最新文献

英文 中文
Translating metagenomics into clinical practice of complex paediatric neurological presentations 将宏基因组学转化为复杂儿科神经学表现的临床实践
Justin Penner, J. Hassell, Julianne R. Brown, K. Mankad, N. Storey, Laura Atkinson, Nisha Ranganathan, Alexander Lennon, Jack C. D. Lee, Dimitrios Champsas, Angelika Kopec, D. Shah, C. Venturini, G. Dixon, S. De, J. Hatcher, K. Harris, K. Aquilina, Maaike Kusters, K. Moshal, D. Shingadia, A. Worth, G. Lucchini, A. Merve, T. Jacques, A. Bamford, M. Kaliakatsos, J. Breuer, S. Morfopoulou
Background Atypical or complex paediatric neurological presentations are common clinical conundrums and often remain undiagnosed despite extensive investigations. This is particularly pronounced in immunocompromised patients. Here we show that clinical metagenomics (CMg) is a valuable adjunct diagnostic tool to be used by neuro-infection multidisciplinary teams (MDTs). Methods We included patients referred to the Great Ormond Street Hospital neuro-infection MDT in whom diagnostic uncertainty remained, despite a standardised comprehensive set of investigations, and who were referred for untargeted CMg on brain tissue and/or cerebrospinal fluid (CSF). In a retrospective review, two clinicians independently assessed whether CMg in conjunction with the MDT resulted in a change of management. Findings 60 undiagnosed patients met the inclusion criteria. We detected the causative pathogen by CMg in 14/60 (23%), with 12/36 patients known to be immunocompromised. CMg results, even when negative, informed patient care, resulting in changes in clinical management in 42/57 (74%). Six patients had unexpected findings of pathogens not identified on prior samples. In four patients, the pathogen was found solely in the brain biopsy and was absent from all other specimens, including CSF. Interpretation CMg is particularly useful when conventional diagnostic techniques for meningoencephalitis are exhausted and proved to be an important diagnostic tool for immunocompromised patients. CMg provided increased reassurance against an infective aetiology prior to recommending immunosuppressive or immunomodulatory treatment. Specialised MDTs should advocate for early brain biopsies and routine CMg in an experienced laboratory for undiagnosed complex neurological cases affecting immunocompromised patients. Funding: the authors declare no funding
背景:非典型或复杂的儿科神经学表现是常见的临床难题,尽管进行了广泛的调查,但往往仍未得到诊断。这在免疫功能低下的患者中尤为明显。在这里,我们表明临床宏基因组学(CMg)是神经感染多学科团队(MDTs)使用的一种有价值的辅助诊断工具。方法:我们纳入了转到大奥蒙德街医院神经感染MDT的患者,尽管进行了标准化的综合调查,但诊断仍不确定,以及转到脑组织和/或脑脊液(CSF)进行非靶向CMg的患者。在一项回顾性研究中,两位临床医生独立评估了CMg联合MDT是否会导致管理方式的改变。结果60例未确诊患者符合纳入标准。我们用CMg检测到14/60(23%)的致病菌,其中12/36的患者已知免疫功能低下。CMg结果,即使阴性,告知患者护理,导致临床管理的改变42/57(74%)。6名患者意外发现了之前样本中未发现的病原体。在4例患者中,仅在脑活检中发现病原体,而在包括脑脊液在内的所有其他标本中均未发现病原体。当脑膜脑炎的常规诊断技术被耗尽时,CMg特别有用,并被证明是免疫功能低下患者的重要诊断工具。在推荐免疫抑制或免疫调节治疗之前,CMg增加了对感染病因的保证。对于影响免疫功能低下患者的未确诊复杂神经病例,专业mdt应提倡在经验丰富的实验室进行早期脑活检和常规CMg。资助:作者声明没有资助
{"title":"Translating metagenomics into clinical practice of complex paediatric neurological presentations","authors":"Justin Penner, J. Hassell, Julianne R. Brown, K. Mankad, N. Storey, Laura Atkinson, Nisha Ranganathan, Alexander Lennon, Jack C. D. Lee, Dimitrios Champsas, Angelika Kopec, D. Shah, C. Venturini, G. Dixon, S. De, J. Hatcher, K. Harris, K. Aquilina, Maaike Kusters, K. Moshal, D. Shingadia, A. Worth, G. Lucchini, A. Merve, T. Jacques, A. Bamford, M. Kaliakatsos, J. Breuer, S. Morfopoulou","doi":"10.1101/2023.06.02.23290816","DOIUrl":"https://doi.org/10.1101/2023.06.02.23290816","url":null,"abstract":"Background Atypical or complex paediatric neurological presentations are common clinical conundrums and often remain undiagnosed despite extensive investigations. This is particularly pronounced in immunocompromised patients. Here we show that clinical metagenomics (CMg) is a valuable adjunct diagnostic tool to be used by neuro-infection multidisciplinary teams (MDTs). Methods We included patients referred to the Great Ormond Street Hospital neuro-infection MDT in whom diagnostic uncertainty remained, despite a standardised comprehensive set of investigations, and who were referred for untargeted CMg on brain tissue and/or cerebrospinal fluid (CSF). In a retrospective review, two clinicians independently assessed whether CMg in conjunction with the MDT resulted in a change of management. Findings 60 undiagnosed patients met the inclusion criteria. We detected the causative pathogen by CMg in 14/60 (23%), with 12/36 patients known to be immunocompromised. CMg results, even when negative, informed patient care, resulting in changes in clinical management in 42/57 (74%). Six patients had unexpected findings of pathogens not identified on prior samples. In four patients, the pathogen was found solely in the brain biopsy and was absent from all other specimens, including CSF. Interpretation CMg is particularly useful when conventional diagnostic techniques for meningoencephalitis are exhausted and proved to be an important diagnostic tool for immunocompromised patients. CMg provided increased reassurance against an infective aetiology prior to recommending immunosuppressive or immunomodulatory treatment. Specialised MDTs should advocate for early brain biopsies and routine CMg in an experienced laboratory for undiagnosed complex neurological cases affecting immunocompromised patients. Funding: the authors declare no funding","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"77 21-22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72454726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Using Thermal Imaging to Measure Hand Hygiene Quality 应用热成像技术测量手卫生质量
Chaofan Wang, Weiwei Jiang, Kangning Yang, Zhanna Sarsenbayeva, Benjamin Tag, Tilman Dingler, Jorge Gonçalves, V. Kostakos
OBJECTIVESHand hygiene has long been promoted as the most effective way to prevent the transmission of infection. However, due to the low compliance and quality of hand hygiene reported in previous studies, constant monitoring of healthcare workers' hand hygiene compliance and quality is crucial. In this study, we investigate the feasibility of using a thermal camera together with an RGB camera to detect hand coverage of alcohol-based formulation, thereby monitoring handrub quality.METHODSWe recruited 32 participants for this study. Participants were required to perform four types of handrubs to produce different hand coverage of alcohol-based formulation. After each task, participants' hands were photographed under a thermal camera and an RGB camera, while an ultraviolet (UV) test was used to provide the ground truth of hand coverage of alcohol-based formulation. Then, a U-Net was used to segment areas covered with alcohol-based formulations from thermal images, and the system performance was evaluated by comparing coverage differences between thermal images and UV images regarding accuracy and Dice coefficient.RESULTSThe system yields promising results in terms of accuracy (93.5%) and Dice coefficient (87.1%) when observations take place 10 seconds after performing handrub. In addition, we also examine the system performance change over a 60-second observation period, and the accuracy and Dice coefficient still remain at about 92.4% and 85.7% when observation happens at the 60-second time point.CONCLUSIONSGiven these encouraging results, thermal imaging shows its potential feasibility in providing accurate, constant, and systematic hand hygiene quality monitoring.
目的手部卫生一直被认为是预防感染传播的最有效途径。然而,由于以往研究报告的手卫生依从性和质量较低,因此持续监测医护人员的手卫生依从性和质量至关重要。在这项研究中,我们探讨了使用热像仪和RGB相机来检测醇基配方的手部覆盖率,从而监测搓手质量的可行性。方法我们招募了32名受试者。参与者被要求进行四种类型的洗手,以产生不同的酒精配方的手部覆盖。每个任务完成后,参与者的手在热像仪和RGB相机下拍照,同时使用紫外线(UV)测试来提供基于酒精的配方的手覆盖率的基本真相。然后,使用U-Net从热图像中分割醇基配方覆盖的区域,并通过比较热图像和UV图像在精度和Dice系数方面的覆盖差异来评估系统性能。结果在洗手后10秒,该系统在准确率(93.5%)和Dice系数(87.1%)方面取得了令人满意的结果。此外,我们还研究了在60秒的观察周期内系统性能的变化,当观察发生在60秒的时间点时,准确率和Dice系数仍然保持在92.4%和85.7%左右。结论热成像技术在提供准确、持续、系统的手卫生质量监测方面具有潜在的可行性。
{"title":"Using Thermal Imaging to Measure Hand Hygiene Quality","authors":"Chaofan Wang, Weiwei Jiang, Kangning Yang, Zhanna Sarsenbayeva, Benjamin Tag, Tilman Dingler, Jorge Gonçalves, V. Kostakos","doi":"10.48550/arXiv.2302.02233","DOIUrl":"https://doi.org/10.48550/arXiv.2302.02233","url":null,"abstract":"OBJECTIVES\u0000Hand hygiene has long been promoted as the most effective way to prevent the transmission of infection. However, due to the low compliance and quality of hand hygiene reported in previous studies, constant monitoring of healthcare workers' hand hygiene compliance and quality is crucial. In this study, we investigate the feasibility of using a thermal camera together with an RGB camera to detect hand coverage of alcohol-based formulation, thereby monitoring handrub quality.\u0000\u0000\u0000METHODS\u0000We recruited 32 participants for this study. Participants were required to perform four types of handrubs to produce different hand coverage of alcohol-based formulation. After each task, participants' hands were photographed under a thermal camera and an RGB camera, while an ultraviolet (UV) test was used to provide the ground truth of hand coverage of alcohol-based formulation. Then, a U-Net was used to segment areas covered with alcohol-based formulations from thermal images, and the system performance was evaluated by comparing coverage differences between thermal images and UV images regarding accuracy and Dice coefficient.\u0000\u0000\u0000RESULTS\u0000The system yields promising results in terms of accuracy (93.5%) and Dice coefficient (87.1%) when observations take place 10 seconds after performing handrub. In addition, we also examine the system performance change over a 60-second observation period, and the accuracy and Dice coefficient still remain at about 92.4% and 85.7% when observation happens at the 60-second time point.\u0000\u0000\u0000CONCLUSIONS\u0000Given these encouraging results, thermal imaging shows its potential feasibility in providing accurate, constant, and systematic hand hygiene quality monitoring.","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89879896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transmission of monkeypox virus through sexual contact - A novel route of infection. 猴痘病毒通过性接触传播——一种新的感染途径。
Joseph Heskin, Amy Belfield, Charlotte Milne, Nicklas Brown, Yasmin Walters, Christopher Scott, Margherita Bracchi, Luke Sp Moore, Nabeela Mughal, Tommy Rampling, Alan Winston, Mark Nelson, Sarah Duncan, Rachael Jones, D Ashley Price, Borja Mora-Peris
{"title":"Transmission of monkeypox virus through sexual contact - A novel route of infection.","authors":"Joseph Heskin, Amy Belfield, Charlotte Milne, Nicklas Brown, Yasmin Walters, Christopher Scott, Margherita Bracchi, Luke Sp Moore, Nabeela Mughal, Tommy Rampling, Alan Winston, Mark Nelson, Sarah Duncan, Rachael Jones, D Ashley Price, Borja Mora-Peris","doi":"10.1016/j.jinf.2022.05.028","DOIUrl":"10.1016/j.jinf.2022.05.028","url":null,"abstract":"","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"14 1","pages":"334-363"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76446750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer. CD24靶向治疗在COVID-19癌症患者中的适用性评估:来自泛癌的初步结果
Bin Wang, Jiantao Fu, Anqian Lu, Jin Yang
{"title":"Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.","authors":"Bin Wang, Jiantao Fu, Anqian Lu, Jin Yang","doi":"10.1016/j.jinf.2022.05.030","DOIUrl":"10.1016/j.jinf.2022.05.030","url":null,"abstract":"","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"42 1","pages":"334-363"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85710210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: an economic evaluation alongside a pragmatic cluster randomised trial. 在接受阿片类药物替代治疗的丙型肝炎患者中,药物主导与传统抗病毒治疗的成本效益:一项经济评估和一项实用的聚类随机试验
G. Myring, Aaron G. Lim, William Hollingworth, Hugh McLeod, Lewis Beer, P. Vickerman, Matthew Hickman, A. Radley, John F. Dillon
BACKGROUNDElimination targets for hepatitis C have been set across the world. In the UK almost 90% of infections are in people who inject drugs. Evidence shows community case-finding is effective at identifying and treating undiagnosed patients. The aim of this analysis was to assess, from a healthcare provider perspective, the cost-effectiveness of a new pharmacist-led test and treat pathway for hepatitis C in opioid agonist treatment (OAT) patients attending community pharmacies compared to conventional care.METHODSIn a cluster randomised controlled trial, pharmacies were randomised to the pharmacist-led or conventional care pathway. Mean cost per OAT patient and per patient initiating treatment was identified for each pathway. A Markov model tracking disease progression was developed, with a 50-year time horizon and 3·5% time discount rate, to estimate the incremental cost-effectiveness ratio (ICER) per quality-adjusted life-year (QALY) gained and the probability of being cost-effective at a £30,000 per QALY willingness-to-pay threshold. Probabilistic sensitivity analysis was performed for a range of drug discounts, re-infection rates, and model assumptions.FINDINGSMean cost per OAT patient (£3,674 vs £1,965) and per patient initiating treatment (£863 vs £404) was higher in the pharmacist-led pathway, due to higher uptake of testing and pharmacist time requirements. Over a 50-year time horizon the ICER per QALY gained was £31,612 at NHS indicative price for treatment (£38,979 for 12 weeks) and 12·1/100 person-years re-infection rate, reducing to £21,027/£10,220/-£501 per QALY gained with 30%/60%/90% drug price discounts and £25,373/£21,738/£14,912 per QALY gained at re-infection rates of 8/5/2 per 100 person-years. At 30%/60%/90% drug discount rates, the pharmacist-led pathway has an 80%/98%/100% probability of being cost-effective.INTERPRETATIONThe pharmacist-led pathway is effective at increasing testing and treatment uptake, with cost-effectiveness being highly dependent on drug price discounts.FUNDINGTrial funding provided by the Scottish Government, Gilead Sciences, and Bristol-Myers Squibb.
背景:世界各地都制定了丙型肝炎的划定目标。在英国,几乎90%的感染发生在注射毒品的人群中。有证据表明,社区病例发现在识别和治疗未确诊患者方面是有效的。本分析的目的是从医疗保健提供者的角度评估,与传统护理相比,在社区药房接受阿片类药物激动剂治疗(OAT)的丙型肝炎患者中,新的药剂师主导的测试和治疗途径的成本效益。方法采用整群随机对照试验,将药店随机分为药师主导路径和常规护理路径。每个OAT患者和每个患者开始治疗的平均成本被确定为每个途径。建立了一个追踪疾病进展的马尔可夫模型,以50年的时间范围和3.5%的时间贴现率来估计每个质量调整生命年(QALY)获得的增量成本-效果比(ICER),以及在每个QALY支付意愿阈值为30,000英镑时具有成本效益的概率。对一系列药物折扣、再感染率和模型假设进行概率敏感性分析。研究结果:在药剂师主导的途径中,每位OAT患者的平均成本(3,674英镑对1,965英镑)和每位开始治疗的患者的平均成本(863英镑对404英镑)更高,这是由于更高的测试吸收和药剂师时间要求。在50年的时间范围内,按NHS治疗指示价格计算,每个QALY获得的ICER为31,612英镑(12周38,979英镑),再感染率为12.1 /100人年,在药品价格折扣30%/60%/90%的情况下,每个QALY获得的ICER降至21,027英镑/ 10,220英镑/- 501英镑,在再感染率为8/5/2 /100人年的情况下,每个QALY获得的ICER降至25,373英镑/ 21,738英镑/ 14,912英镑。在30%/60%/90%的药物折扣率下,药剂师主导的途径具有80%/98%/100%的成本效益概率。药师主导的途径在增加检测和治疗吸收方面是有效的,其成本效益高度依赖于药品价格折扣。资助:试验资金由苏格兰政府、吉利德科学公司和百时美施贵宝公司提供。
{"title":"Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: an economic evaluation alongside a pragmatic cluster randomised trial.","authors":"G. Myring, Aaron G. Lim, William Hollingworth, Hugh McLeod, Lewis Beer, P. Vickerman, Matthew Hickman, A. Radley, John F. Dillon","doi":"10.2139/ssrn.4019338","DOIUrl":"https://doi.org/10.2139/ssrn.4019338","url":null,"abstract":"BACKGROUND\u0000Elimination targets for hepatitis C have been set across the world. In the UK almost 90% of infections are in people who inject drugs. Evidence shows community case-finding is effective at identifying and treating undiagnosed patients. The aim of this analysis was to assess, from a healthcare provider perspective, the cost-effectiveness of a new pharmacist-led test and treat pathway for hepatitis C in opioid agonist treatment (OAT) patients attending community pharmacies compared to conventional care.\u0000\u0000\u0000METHODS\u0000In a cluster randomised controlled trial, pharmacies were randomised to the pharmacist-led or conventional care pathway. Mean cost per OAT patient and per patient initiating treatment was identified for each pathway. A Markov model tracking disease progression was developed, with a 50-year time horizon and 3·5% time discount rate, to estimate the incremental cost-effectiveness ratio (ICER) per quality-adjusted life-year (QALY) gained and the probability of being cost-effective at a £30,000 per QALY willingness-to-pay threshold. Probabilistic sensitivity analysis was performed for a range of drug discounts, re-infection rates, and model assumptions.\u0000\u0000\u0000FINDINGS\u0000Mean cost per OAT patient (£3,674 vs £1,965) and per patient initiating treatment (£863 vs £404) was higher in the pharmacist-led pathway, due to higher uptake of testing and pharmacist time requirements. Over a 50-year time horizon the ICER per QALY gained was £31,612 at NHS indicative price for treatment (£38,979 for 12 weeks) and 12·1/100 person-years re-infection rate, reducing to £21,027/£10,220/-£501 per QALY gained with 30%/60%/90% drug price discounts and £25,373/£21,738/£14,912 per QALY gained at re-infection rates of 8/5/2 per 100 person-years. At 30%/60%/90% drug discount rates, the pharmacist-led pathway has an 80%/98%/100% probability of being cost-effective.\u0000\u0000\u0000INTERPRETATION\u0000The pharmacist-led pathway is effective at increasing testing and treatment uptake, with cost-effectiveness being highly dependent on drug price discounts.\u0000\u0000\u0000FUNDING\u0000Trial funding provided by the Scottish Government, Gilead Sciences, and Bristol-Myers Squibb.","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83958649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Gargle pool PCR testing in a hospital during medium and high SARS-CoV-2 incidence. 某医院SARS-CoV-2中高发期含漱池PCR检测
P Kheiroddin, V D Gaertner, P Schöberl, E Fischer, J Niggel, P Pagel, B M J Lampl, A Ambrosch, M Kabesch

Background: Hospitals need to be protected from SARS-CoV-2 infections to protect vulnerable patients. Thus, a safe, efficient, and cost-effective SARS-CoV-2 testing system for hospitals, in addition to standard hygiene measures and vaccination of staff, is necessary. Here we report on the feasibility and performance of a pool real-time reverse-transcriptase polymerase-chain-reaction (rRT-PCR) test system at, medium and high incidence.

Methods: We implemented a testing concept based on gargling at home and pooling of samples in the hospital before PCR testing in the laboratory. We used two PCR systems (point of care and standard 96-well plate system) to adapt to challenges in the hospital setting and respond to a rising incidence in the Omicron wave.

Findings: During our 10-week study period, we performed 697 pool PCRs (8793 tests in total) and identified 65 asymptomatic staff members by pool PCR and 94 symptomatic staff members by positive individual PCR. Virus loads in those detected by pool testing were significantly lower (P<0.001). The test system remained workable even during the peak of the Omicron wave and no outbreaks occurred in any specific area of the hospital during the study period. Unvaccinated individuals were over-represented in the positively tested (37% vs 22% positive tests, P=0.04). The test procedure was well accepted by a majority of the hospital staff (84%).

Conclusion: Repeated gargle pool rRT-PCR testing can be implemented quickly in hospitals and is an effective, easily adaptable and well-accepted test system for hospitals, even during phases with very high infection rates.

背景:需要保护医院免受SARS-CoV-2感染,以保护弱势患者。因此,除了标准的卫生措施和工作人员的疫苗接种外,还需要为医院建立安全、高效和具有成本效益的SARS-CoV-2检测系统。在这里,我们报告了池实时逆转录酶聚合酶链反应(rRT-PCR)检测系统在,中,高发病率的可行性和性能。方法:在实验室进行PCR检测前,先在家中漱口,再在医院收集样本。我们使用两种PCR系统(护理点和标准96孔板系统)来适应医院环境的挑战,并应对欧米克隆波发生率的上升。结果:在为期10周的研究期间,我们进行了697次池PCR(共8793次检测),通过池PCR鉴定出65名无症状工作人员,通过阳性个体PCR鉴定出94名有症状的工作人员。结论:反复漱口池rRT-PCR检测可在医院快速实施,是一种有效的、适应性强的、被医院广泛接受的检测系统,即使在感染率很高的阶段也是如此。
{"title":"Gargle pool PCR testing in a hospital during medium and high SARS-CoV-2 incidence.","authors":"P Kheiroddin, V D Gaertner, P Schöberl, E Fischer, J Niggel, P Pagel, B M J Lampl, A Ambrosch, M Kabesch","doi":"10.1016/j.jhin.2022.05.018","DOIUrl":"10.1016/j.jhin.2022.05.018","url":null,"abstract":"<p><strong>Background: </strong>Hospitals need to be protected from SARS-CoV-2 infections to protect vulnerable patients. Thus, a safe, efficient, and cost-effective SARS-CoV-2 testing system for hospitals, in addition to standard hygiene measures and vaccination of staff, is necessary. Here we report on the feasibility and performance of a pool real-time reverse-transcriptase polymerase-chain-reaction (rRT-PCR) test system at, medium and high incidence.</p><p><strong>Methods: </strong>We implemented a testing concept based on gargling at home and pooling of samples in the hospital before PCR testing in the laboratory. We used two PCR systems (point of care and standard 96-well plate system) to adapt to challenges in the hospital setting and respond to a rising incidence in the Omicron wave.</p><p><strong>Findings: </strong>During our 10-week study period, we performed 697 pool PCRs (8793 tests in total) and identified 65 asymptomatic staff members by pool PCR and 94 symptomatic staff members by positive individual PCR. Virus loads in those detected by pool testing were significantly lower (P<0.001). The test system remained workable even during the peak of the Omicron wave and no outbreaks occurred in any specific area of the hospital during the study period. Unvaccinated individuals were over-represented in the positively tested (37% vs 22% positive tests, P=0.04). The test procedure was well accepted by a majority of the hospital staff (84%).</p><p><strong>Conclusion: </strong>Repeated gargle pool rRT-PCR testing can be implemented quickly in hospitals and is an effective, easily adaptable and well-accepted test system for hospitals, even during phases with very high infection rates.</p>","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"39 1","pages":"69-76"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88824924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage 印度发现猴痘病例的基因组特征:A.2谱系中三个亚群的鉴定
A. Shete, P. Yadav, Abhinendra Kumar, S. V. Patil, D. Patil, Yash Joshi, T. Majumdar, V. Relhan, R. Sahay, Meenakshy Vasu, P. Gawande, Ajay Verma, Arbind Kumar, Shivram Dhakad, Anukumar Bala Krishnan, Shubin Chenayil, Suresh Kumar, P. Abraham
Since May 2022, Monkeypox, a zoonotic Orthopox DNA virus was reported in more than 102 countries indicating expansion of its geographic range. We analyzed the complete genomes sequences of Monkeypox cases from Kerala (n=5 travelled from UAE) and Delhi (n=5 no travel history), India confirmed during July to August 2022. All the retrieved MPXV sequences from India covering 90 to 99% genome belong to A.2 lineage of clade IIb. The A.2 MPXV lineage divided in three sub clusters; first cluster Kerala n=5, Delhi n=2 aligned with the USA-2022 ON674051.1; while second of Delhi n=3 aligned with USA-2022 ON675438.1 and third consists of the UK, USA and Thailand. Recent update in MPXV lineage designated all the five sequences from Kerala as A.2.1. In addition to known 16 single nucleotide polymorphisms (SNPs) along with 13 APOBEC3 cytosine deaminase activity determined specific lineage defining mutations in A.2 lineage, 25 additional APOBEC3 mutations were found in 10 reported sequences. The study emphasizes need of enhancing genomic surveillance to understand the mutation and its linkage.
自2022年5月以来,在102多个国家报告了猴痘,这是一种人畜共患的正痘DNA病毒,表明其地理范围扩大。我们分析了2022年7月至8月确诊的印度喀拉拉邦(n=5例来自阿联酋)和德里(n=5例无旅行史)猴痘病例的全基因组序列。所有从印度检索到的MPXV序列覆盖90% ~ 99%的基因组,均属于IIb支系A.2谱系。A.2 MPXV谱系分为三个亚群;第一集群喀拉拉邦n=5,德里n=2与美国对齐-2022 ON674051.1;德里n=3与美国-2022 ON675438.1一致,第三个由英国、美国和泰国组成。最近MPXV谱系的更新将所有来自喀拉拉邦的五个序列指定为A.2.1。除了已知的16个单核苷酸多态性(snp)和13个APOBEC3胞嘧啶脱氨酶活性决定了A.2谱系中定义突变的特定谱系外,在10个已报道的序列中发现了25个APOBEC3突变。该研究强调需要加强基因组监测,以了解突变及其联系。
{"title":"Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage","authors":"A. Shete, P. Yadav, Abhinendra Kumar, S. V. Patil, D. Patil, Yash Joshi, T. Majumdar, V. Relhan, R. Sahay, Meenakshy Vasu, P. Gawande, Ajay Verma, Arbind Kumar, Shivram Dhakad, Anukumar Bala Krishnan, Shubin Chenayil, Suresh Kumar, P. Abraham","doi":"10.1101/2022.09.16.507742","DOIUrl":"https://doi.org/10.1101/2022.09.16.507742","url":null,"abstract":"Since May 2022, Monkeypox, a zoonotic Orthopox DNA virus was reported in more than 102 countries indicating expansion of its geographic range. We analyzed the complete genomes sequences of Monkeypox cases from Kerala (n=5 travelled from UAE) and Delhi (n=5 no travel history), India confirmed during July to August 2022. All the retrieved MPXV sequences from India covering 90 to 99% genome belong to A.2 lineage of clade IIb. The A.2 MPXV lineage divided in three sub clusters; first cluster Kerala n=5, Delhi n=2 aligned with the USA-2022 ON674051.1; while second of Delhi n=3 aligned with USA-2022 ON675438.1 and third consists of the UK, USA and Thailand. Recent update in MPXV lineage designated all the five sequences from Kerala as A.2.1. In addition to known 16 single nucleotide polymorphisms (SNPs) along with 13 APOBEC3 cytosine deaminase activity determined specific lineage defining mutations in A.2 lineage, 25 additional APOBEC3 mutations were found in 10 reported sequences. The study emphasizes need of enhancing genomic surveillance to understand the mutation and its linkage.","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"81 1","pages":"66 - 117"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78275521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Multidrug-resistant OXA-48/CTX-M-15 Klebsiella pneumoniae cluster in a COVID-19 intensive care unit: salient lessons for infection prevention and control during the COVID-19 pandemic. COVID-19重症监护病房中的多重耐药OXA-48/CTX-M-15肺炎克雷伯菌聚集:COVID-19大流行期间预防和控制感染的重要经验教训
A R Howard-Jones, I Sandaradura, R Robinson, S R Orde, J Iredell, A Ginn, S van Hal, J Branley

Background: Wards caring for COVID-19 patients, including intensive care units (ICUs), have an important focus on preventing transmission of SARS-CoV-2 to other patients and healthcare workers.

Aim: To describe an outbreak of carbapenemase-producing Enterobacterales (CPE) in a COVID-19 ICU and to discuss key infection control measures enabling prompt termination of the cluster.

Methods: CPE were isolated from clinical specimens and screening swabs from intensive care patients with COVID-19 disease and from environmental screening. Whole-genome sequencing analysis was instrumental in informing phylogenetic relationships.

Findings: Seven clinical isolates and one environmental carbapenemase-producing Klebsiella pneumoniae isolate - all carrying OXA-48, CTX-M-15 and outer membrane porin mutations in ompK35/ompK36 - were identified with ≤1 single nucleotide polymorphism difference, indicative of clonality. A bundle of infection control interventions including careful adherence with contact precautions and hand hygiene, twice weekly screening for multidrug-resistant organisms, strict antimicrobial stewardship, and enhanced cleaning protocols promptly terminated the outbreak.

Conclusion: Prolonged use of personal protective equipment is common with donning and doffing stations at the ward entrance, leaving healthcare workers prone to reduced hand hygiene practices between patients. Minimizing transmission of pathogens other than SARS-CoV-2 by careful adherence to normal contact precautions including hand hygiene, even during high patient contact manoeuvres, is critical to prevent outbreaks of multidrug-resistant organisms. Appropriate antimicrobial stewardship and screening for multidrug-resistant organisms must also be maintained throughout surge periods to prevent medium-term escalation in antimicrobial resistance rates. Whole-genome sequencing is highly informative for multidrug-resistant Enterobacterales surveillance strategies.

背景:护理COVID-19患者的病房,包括重症监护病房(icu),重点是防止SARS-CoV-2传播给其他患者和医护人员。目的:描述2019冠状病毒病疫情ICU中产碳青霉烯酶肠杆菌(CPE)的爆发情况,并探讨能够及时终止该聚集性感染的关键感染控制措施。方法:从COVID-19重症监护患者临床标本、筛查拭子和环境筛查中分离CPE。全基因组测序分析有助于了解系统发育关系。结果:7株临床分离株和1株环境产碳青霉烯酶肺炎克雷伯菌分离株均携带OXA-48、CTX-M-15和外膜孔蛋白ompK35/ompK36突变,单核苷酸多态性差异≤1,表明克隆性。一系列感染控制干预措施,包括严格遵守接触预防措施和手卫生,每周两次筛查耐多药微生物,严格的抗微生物管理以及加强清洁方案,迅速终止了疫情。结论:长期使用个人防护装备是常见的,在病房入口处的穿戴和脱布站,使卫生工作者容易减少患者之间的手部卫生习惯。通过严格遵守正常的接触预防措施,包括手卫生,尽量减少SARS-CoV-2以外病原体的传播,即使在高度接触患者的过程中也是如此,这对于防止多重耐药生物的爆发至关重要。还必须在激增期间保持适当的抗菌素管理和多重耐药生物筛查,以防止中期抗菌素耐药率上升。全基因组测序对多药耐药肠杆菌监测策略具有高度信息性。
{"title":"Multidrug-resistant OXA-48/CTX-M-15 Klebsiella pneumoniae cluster in a COVID-19 intensive care unit: salient lessons for infection prevention and control during the COVID-19 pandemic.","authors":"A R Howard-Jones, I Sandaradura, R Robinson, S R Orde, J Iredell, A Ginn, S van Hal, J Branley","doi":"10.1016/j.jhin.2022.05.001","DOIUrl":"10.1016/j.jhin.2022.05.001","url":null,"abstract":"<p><strong>Background: </strong>Wards caring for COVID-19 patients, including intensive care units (ICUs), have an important focus on preventing transmission of SARS-CoV-2 to other patients and healthcare workers.</p><p><strong>Aim: </strong>To describe an outbreak of carbapenemase-producing Enterobacterales (CPE) in a COVID-19 ICU and to discuss key infection control measures enabling prompt termination of the cluster.</p><p><strong>Methods: </strong>CPE were isolated from clinical specimens and screening swabs from intensive care patients with COVID-19 disease and from environmental screening. Whole-genome sequencing analysis was instrumental in informing phylogenetic relationships.</p><p><strong>Findings: </strong>Seven clinical isolates and one environmental carbapenemase-producing Klebsiella pneumoniae isolate - all carrying OXA-48, CTX-M-15 and outer membrane porin mutations in ompK35/ompK36 - were identified with ≤1 single nucleotide polymorphism difference, indicative of clonality. A bundle of infection control interventions including careful adherence with contact precautions and hand hygiene, twice weekly screening for multidrug-resistant organisms, strict antimicrobial stewardship, and enhanced cleaning protocols promptly terminated the outbreak.</p><p><strong>Conclusion: </strong>Prolonged use of personal protective equipment is common with donning and doffing stations at the ward entrance, leaving healthcare workers prone to reduced hand hygiene practices between patients. Minimizing transmission of pathogens other than SARS-CoV-2 by careful adherence to normal contact precautions including hand hygiene, even during high patient contact manoeuvres, is critical to prevent outbreaks of multidrug-resistant organisms. Appropriate antimicrobial stewardship and screening for multidrug-resistant organisms must also be maintained throughout surge periods to prevent medium-term escalation in antimicrobial resistance rates. Whole-genome sequencing is highly informative for multidrug-resistant Enterobacterales surveillance strategies.</p>","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"1 1","pages":"64-69"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84178552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A distinct phylogenetic cluster of Monkeypox genomes suggests an early and cryptic spread of the virus 猴痘基因组的一个明显的系统发育集群表明该病毒的早期和隐性传播
B. Jolly, V. Scaria
Since its first reports in humans in 1970, monkeypox has been predominantly restricted to countries in Africa where the disease is endemic. Early in 2022, a large number of cases of the disease were reported from Europe and other countries in patients having no history of travel to regions where monkeypox is endemic. Amid a rise in cases, the availability of genome sequences of monkeypox virus isolates in the public domain provides an opportunity to understand the transmission and evolution of the virus. Here, we describe a distinct phylogenetic cluster of monkeypox virus (lineage A.2) using genome sequences available on GISAID. Lineage A.2 currently encompasses 9 genome sequences from 6 viral isolates collected from 3 countries and is distinctly different from the predominant lineage B.1 which is linked to the large European outbreak.
自1970年首次在人类中报告猴痘以来,猴痘主要局限于该疾病流行的非洲国家。2022年初,欧洲和其他国家报告了大量猴痘病例,患者没有前往猴痘流行地区的旅行史。在病例增加的情况下,公共领域中猴痘病毒分离物基因组序列的可用性为了解病毒的传播和进化提供了机会。在这里,我们使用GISAID上的基因组序列描述了猴痘病毒(谱系a .2)的一个独特的系统发育集群。谱系A.2目前包含从3个国家收集的6个病毒分离株的9个基因组序列,与与欧洲大暴发有关的主要谱系B.1明显不同。
{"title":"A distinct phylogenetic cluster of Monkeypox genomes suggests an early and cryptic spread of the virus","authors":"B. Jolly, V. Scaria","doi":"10.1101/2022.07.30.502168","DOIUrl":"https://doi.org/10.1101/2022.07.30.502168","url":null,"abstract":"Since its first reports in humans in 1970, monkeypox has been predominantly restricted to countries in Africa where the disease is endemic. Early in 2022, a large number of cases of the disease were reported from Europe and other countries in patients having no history of travel to regions where monkeypox is endemic. Amid a rise in cases, the availability of genome sequences of monkeypox virus isolates in the public domain provides an opportunity to understand the transmission and evolution of the virus. Here, we describe a distinct phylogenetic cluster of monkeypox virus (lineage A.2) using genome sequences available on GISAID. Lineage A.2 currently encompasses 9 genome sequences from 6 viral isolates collected from 3 countries and is distinctly different from the predominant lineage B.1 which is linked to the large European outbreak.","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"75 3","pages":"e24 - e26"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72478684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Emergence of blaKPC-33-harboring Hypervirulent ST463 Pseudomonas aeruginosa Causing Fatal Infections in China. 携带blakpc -33的高毒力ST463铜绿假单胞菌在中国引起致命感染的出现
Piao-piao Zhang, Jie Wang, Yue Li, Weixiao Shi, Heng Cai, Q. Yang, X. Li, Yunsong Yu, Ting-ting Qu, Yan Jiang
{"title":"Emergence of blaKPC-33-harboring Hypervirulent ST463 Pseudomonas aeruginosa Causing Fatal Infections in China.","authors":"Piao-piao Zhang, Jie Wang, Yue Li, Weixiao Shi, Heng Cai, Q. Yang, X. Li, Yunsong Yu, Ting-ting Qu, Yan Jiang","doi":"10.2139/ssrn.4074661","DOIUrl":"https://doi.org/10.2139/ssrn.4074661","url":null,"abstract":"","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73389297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1